David J. Kuter, MD, PhD

Professor, Department of Medicine, Harvard Medical School

Director, Clinical Hematology, Massachusetts General Hospital

Contact Info

David Kuter
Massachusetts General Hospital
100 Blossom Street
Boston, MA, 02114
Mailstop: Hematology/Oncology Unit, Cox 640
Phone: 617-726-8743
Fax: 617-724-3166
kuter.david@mgh.harvard.edu

Assistant

Maureen Lucey
Assistant
Hematology
Massachusetts General Hospital
32 Fruit Street
Boston, MA, 02114
Mailstop: Yawkey 7 - 7945
Phone: 617-726-8743
Fax: 617-643-1915
mlucey@partners.org

DF/HCC Program Affiliation

Leukemia

Research Abstract

My basic science research involves hematopoiesis. We investigate the mechanism of apoptosis in megakaryocytes and platelets. We also assess the molecular mechanism by which thrombopoietin is regulated and interacts with its receptor, c-Mpl. My clinical research is focussed on thrombosis/hemostasis and hematopoietic growth factors. We are studying the use of thrombopoietin in ITP, the use of Novel Erythropoiesis-Stimulating Protein (NESP) in anemic chemotherapy patients and the role of thrombopoietin in preventing chemotherapy-induced thrombocytopenia. We are studying the thrombophilia of malignancy and the role of low-molecular weight heparins in its treatment and in the prevention of catheter-related thrombosis.

Publications

View All Publications

Advanced search
DF/HCC Directory Login Update Member Profile Change Account Settings Applying for Membership Benefits Requirements Responsibilities	David J. Kuter, MD, PhD Professor, Department of Medicine, Harvard Medical School Director, Clinical Hematology, Massachusetts General Hospital Contact Info David Kuter Massachusetts General Hospital 100 Blossom Street Boston, MA, 02114 Mailstop: Hematology/Oncology Unit, Cox 640 Phone: 617-726-8743 Fax: 617-724-3166 kuter.david@mgh.harvard.edu Assistant Maureen Lucey Assistant Hematology Massachusetts General Hospital 32 Fruit Street Boston, MA, 02114 Mailstop: Yawkey 7 - 7945 Phone: 617-726-8743 Fax: 617-643-1915 mlucey@partners.org DF/HCC Program Affiliation Leukemia Research Abstract My basic science research involves hematopoiesis. We investigate the mechanism of apoptosis in megakaryocytes and platelets. We also assess the molecular mechanism by which thrombopoietin is regulated and interacts with its receptor, c-Mpl. My clinical research is focussed on thrombosis/hemostasis and hematopoietic growth factors. We are studying the use of thrombopoietin in ITP, the use of Novel Erythropoiesis-Stimulating Protein (NESP) in anemic chemotherapy patients and the role of thrombopoietin in preventing chemotherapy-induced thrombocytopenia. We are studying the thrombophilia of malignancy and the role of low-molecular weight heparins in its treatment and in the prevention of catheter-related thrombosis. Publications View All Publications
Site Map Site Feedback Web Privacy Policy